Username
Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in a childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.
Blogs by Author
Clinical & Pharma, Science of the Future
Developing Ways to Diagnose Alzheimer’s Disease EarlyScientists are searching for biochemical changes in body fluids that are early indicators of Alzheimer’s disease. A new study opens the door for investigating their potential as diagnostic markers
Environment & Sustainability, Water In The Lab
Cutting Back On Laboratory Plastic WasteThe world is now sitting up and taking action to prevent millions of tonnes of plastic waste ending up in landfill and our oceans. But with many scientific laboratories still relying heavily on disposable plastics, is it time to find ways to cut back?
Cool Science, Science of the Future
A New Step Towards Releasing the Full Potential of GrapheneUltrapure water prepared using a PURELAB system is a key reagent in a simple new method for producing graphene, paving the way for scientists to unlock more opportunities promised by graphene
Clinical & Pharma, Science of the Future
ELGA PURELAB Helps Standardize Antibiotic Susceptibility TestingA new study makes recommendations for combining two different methods to test bacterial susceptibility to antibiotics, which could help improve reproducibility between laboratories and provide more clinically relevant information for treating infections
Clinical & Pharma, Cool Science
Targeting Drug Delivery to the Brain Using Inhaled Microparticle AgglomeratesUltrapure water is a key reagent in a new study showing that a new inhaled powder formulation may be an effective way to deliver an anti-viral drug to the brain, offering a new approach for treating central nervous system (CNS) infections
